Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
339
NCT03627715
Safety and Effectiveness of Propagermanium in Diabetic Kidney Disease Participants Receiving Irbesartan
Phase: Phase 2
Role: Lead Sponsor
Start: Nov 6, 2018
Completion: Aug 18, 2020
NCT03649152
Safety and Effectiveness of Propagermanium in Focal Segmental Glomerulosclerosis Participants Receiving Irbesartan
Start: Nov 8, 2018
Completion: Jul 13, 2020
NCT05183646
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
Phase: Phase 3
Start: May 30, 2022
Completion: Dec 31, 2029